AHR and colitis: Indole derivatives confer protection in murine models of colitis, largely via AhR activation, leading to increased IL-22 production by ILC3s and T cells that drives improved intestinal barrier integrity, reduced inflammation, and, ultimately, disease amelioration [20, 22, 28, 62–64].